The TITAN clinical trial has demonstrated that the addition of apalutamide to androgen-deprivation therapy significantly improved radiographic progression-free survival and overall survival in patients with metastatic castration-sensitive prostate cancer. These results were presented by Dr. Kim Chi at ASCO on May 31, and were written up on ASCO Daily News on June 1. Dr.
May 4, 2019 - Dr. Martin Gleave gave the AUA 2019's Ramon Guiteras Lecture, a plenary invited lecture named after the AUA's founder. Click here to read the original story at AUA Daily News, the text of which is copied below.
St. Baldrick’s Foundation Awards One-of-a-Kind Grant to Aid in Childhood Cancer Research Discovery: St. Baldrick’s Robert J. Arceci Innovation Award provides scientists opportunity to pursue unrestricted research
April 17, 2019 - Dr. Sriram Subramaniam has joined the University of British Columbia (UBC) as the Gobind Khorana Canada Excellence Research Chair in Precision Cancer Drug Design.
Dr. Subramaniam is recognized as a global leader in the emerging field of cryo-electron microscopy, or cryo-EM, a technology that has sparked a revolution in imaging of protein complexes. He is appointed both in the Department of Urologic Sciences and in Biochemistry and Molecular biology at UBC and is linked to the precision cancer drug design program at the Vancouver Prostate Centre.
A recent publication from Dr Xuesen Dong and team is featured as...
The Vancouver Prostate Centre is pleased to announce the appointment of Don Mattrick to our Board of Directors.
Don is currently is co-founder and co-president of MdGB Capital, a private company that manages a group assets and operating companies throughout North America.
The UBC Faculty of Medicine today published "Translating research to treat prostate cancer" - a profile of the translational research breakthroughs being made at our Centre. Featuring our Executive Director Dr. Gleave, the article discusses the innovative potential therapeutics discovered by Drs. Rennie, Cherkasov and Zoubeidi.
February 25, 2019 - Scientists at the University of British Columbia have discovered a new protein “switch” that could stop the progression of blood-poisoning, or sepsis, and increase the chances of surviving the life-threatening disease.
Dr. Amina Zoubeidi was featured in articles on VCHRI News and Prostate Cancer Canada on February 11, 2019, the International Day of Women and Girls in Science.
The VCHRI News article, "Ask an expert: Who runs the (science) world?" contains interviews with three researchers at VCHRI who share their experiences and offer advice for the next generation of women scientists.
Dr YZ Wang and his co-applicants Drs Ci, He and Lin were the recipients of a five-year CIHR Project Grant (Fall 2018 competition) for their proposal titled "Function and therapeutic potential of SUV420H2 in neuroendocrine prostate cancer."
Three VPC trainees received Prostate Cancer Foundation BC research grants: